Law360, New York (January 24, 2012, 8:25 PM ET) -- Weil Gotshal & Manges LLP represented French drug maker Sanofi SA in its pursuit of Massachusetts-based biotechnology company Genzyme Corp., using an unusual strategy to win over shareholders and turning what began as a hostile bid into a friendly $20.1 billion takeover, landing the firm a place among Law360’s Health Groups of 2011.
After Genzyme shareholders resisted Sanofi’s initial $69 per share in cash bid, Weil Gotshal’s attorneys worked on conciliatory strategies, turning the deal friendly in February 2011 with a $74 per share offer and...
Health Group Of The Year: Weil Gotshal & Manges
To view the full article, take a free trial now.
